Most radiology practice owners lose pricing on their lines of credit because their banker has never been taught what a chargemaster is. The gross A/R on your aging report is not your expected cash, and the 120+ day bucket is not a collection problem — both are structural features of how healthcare billing works. If your credit team is applying a commercial-A/R borrowing base to your radiology receivables, they are mispricing you.
Key Takeaway: Three numbers matter in healthcare banking, not one. Gross charges billed, cash collected, and the Net Collection Rate between them. For a Florida radiology practice, a 25–35% Net Collection Rate with 55–60% of gross A/R in 120+ days is normal and healthy — it reflects the chargemaster-to-contract spread and the LOP settlement cycle, not bad debt. Your job as the borrower is to translate the aging report into that framework before the credit committee applies the wrong formula to it.
The Three-Number Framework Every Radiology Borrower Needs
In a commercial business, the gross amount on an aging report is roughly the amount the business expects to collect. A $100,000 invoice means $100,000 in expected cash. Commercial banks are trained on that model, and it works fine for a manufacturer or a service business that bills at the rate it expects to be paid.
Healthcare does not work that way. A radiology practice bills every CPT code at the chargemaster rate — a standardized list price the practice publishes. Every insurance contract, Medicare fee schedule, PIP statutory cap, and negotiated commercial rate then reduces that gross bill to a contracted reimbursement amount at the point of payment. The difference between the list price and the contract price is recognized as a contractual allowance, not a bad debt.
This means the three numbers a radiology banker actually needs to see are:
| Number | What it is | Why it matters |
|---|---|---|
| Gross charges billed | Total chargemaster billings for the period | Ceiling, not expectation |
| Cash collected | Actual deposits from operating account | The real revenue line |
| Net Collection Rate | Cash collected ÷ gross charges | The only KPI that matters |
Everything else — the aging buckets, the 120+ concentration, the LOP balance — is downstream of these three. If the first three numbers are stable and the ratio between them is consistent with industry benchmarks, your A/R is working correctly, regardless of what the aging visual looks like.
How a Radiology Chargemaster Actually Works
A chargemaster is the published list price a healthcare provider assigns to each procedure code. It is intentionally set well above what any payer will actually reimburse, for two reasons: billing compliance (you cannot charge one payer more than your published rate) and negotiating leverage (the chargemaster is the anchor from which commercial contracts negotiate down).
When a claim goes out, the practice bills the chargemaster rate. When the payment comes in, the payer remits the contracted rate — their fee schedule amount — and the difference is written off as a contractual allowance. For a typical Florida imaging center, the chargemaster is two to four times the average contracted rate, depending on payer mix.
This is not a leak. It is the model. The Centers for Medicare & Medicaid Services publishes the Medicare Physician Fee Schedule that sets the floor for most reimbursement negotiations, and every commercial contract is priced as a percentage of Medicare. A $1,200 MRI at chargemaster might settle to $380 with a commercial payer, $290 with Medicare, or $1,000 on a PIP claim capped at the Florida statutory limit. Same scan, same staff, same day — three different realized rates.
The aging report, meanwhile, shows the $1,200 sitting in A/R until the payment posts. When the payer finally pays $290 and the $910 write-off clears, the A/R balance drops by the full $1,200 — but the cash that came in was $290. If you are reading the aging report as a cash proxy, you will dramatically overstate what the practice expects to collect.
Net Collection Rate Is the Only Radiology KPI That Matters
The Net Collection Rate is cash posted to the operating account, divided by gross charges billed over the same period. It collapses the entire chargemaster-to-contract spread into one number that a banker can actually use.
For a Florida radiology practice, typical NCR benchmarks by payer mix look like this:
| Payer Mix Profile | Typical NCR Range |
|---|---|
| Commercial-heavy (PPO, HMO, Medicare Advantage) | 28–35% |
| Balanced mix (commercial + PIP + some LOP) | 25–32% |
| Heavy LOP concentration (35%+ of A/R) | 15–25% on current-period data* |
| Heavy research / clinical trial receivables | 40–55% (contracted B2B) |
*LOP-heavy practices show a mechanically lower current-period NCR because charges are recognized immediately but cash realizes over a 12–36 month settlement window. On a steady-state multi-year basis, the economics are similar — the timing is just stretched.
A practice running at 30% NCR is not collecting "30 cents on the dollar." It is billing at 3.3x the realized rate and collecting every dollar the contracts entitle it to. The Healthcare Financial Management Association's revenue cycle benchmarks treat NCR stability, not the absolute number, as the indicator of billing health.
Reading a Radiology Aging Report by Payer Class
Once the NCR frames the top-line economics, the aging report starts making sense when you read it by payer class rather than by aging bucket. Different payers settle on completely different cycles, and a healthy A/R will always have something sitting in 120+ days regardless of how well the billing team is running.
Here is how the major payer classes behave in a Florida radiology practice:
| Payer Class | Collection Cycle | % of Typical A/R | Aging Behavior |
|---|---|---|---|
| PIP / Auto (Progressive, State Farm, GEICO, Allstate) | 30–60 days | 5–15% | Clears fast, rarely hits 120+ |
| Commercial (FL Blue, United, Cigna, Aetna, Humana) | 30–60 days | 20–35% | Mostly 0–90, small 120+ tail |
| Medicare + Medicare Advantage | 30–45 days | 10–25% | Deterministic, very fast |
| LOP / Personal Injury | 12–36 months | 25–45% | Almost entirely 120+ |
| Research / Clinical Trial | 30–60 days | 0–15% | Contracted B2B, behaves like commercial |
| Patient / Self-Pay | 60–120 days | 3–12% | Slowest insurance-style collection |
The 120+ concentration you see on the aging report is driven almost entirely by the LOP segment. An imaging center with 40% LOP in its A/R will show something like 55–60% in 120+ days no matter how well the billing team is running, because LOP settlements take one to three years to clear through the personal injury litigation cycle. That is not a collection problem. That is the settlement calendar of the Florida plaintiffs' bar.
A banker looking at this report without the payer-class overlay will see "58% over 120 days" and apply a 50% borrowing-base haircut. The same banker looking at the report with the overlay will see a healthy, diversified receivable book with a long-tail asset class that happens to carry 12-to-36-month duration. Those are two completely different credit conclusions from identical data.
LOP Counterparty Quality: Why 120+ Days Is Not Stale Paper
The LOP segment is where most of a credit team's unease comes from, and it is almost always based on a single misread: the assumption that LOP paper is sitting against unknown or fly-by-night law firms. In the Florida market, nothing could be further from reality.
The top LOP counterparties on most South Florida and Jacksonville radiology practices include:
- Morgan & Morgan, P.A. — the largest personal injury law firm in the United States, 1,000+ attorneys across 50+ offices, $2 billion+ in annual revenue, and a multi-decade track record of settling cases and paying medical providers on executed letters of protection.
- Farah & Farah — one of the oldest and largest personal injury firms in the Southeast.
- Steinger, Greene & Feiner — long-operating high-volume Florida personal injury practice.
- Pelosi Injury Law, Rubenstein Law, and similar established Florida PI firms, each with multi-decade settlement histories and well-documented payment practices.
We recently worked with a Jacksonville imaging center carrying a $13.78 million gross A/R portfolio against a monthly realized cash run rate of approximately $418,000 per month. The LOP tail alone delivered $1.25 million in realized cash over the trailing twelve months — roughly $104,000 a month, every month, for twelve consecutive months. Not theoretical. Not "eventual." Actual deposits, reconciled from QuickBooks, across a diversified counterparty base led by the top five names in the Florida plaintiffs' bar. When we laid that out for the credit committee, the underwriter's concern about "stale LOP paper" evaporated inside a single paragraph.
A Broward-area center we reviewed in the same month was carrying 41% of its gross A/R in LOP, with top counterparties from the same tier-1 firm list. The aging report looked alarming on its face. The monthly cash collections, once normalized for deposit timing, were running above $400,000 with coefficient of variation under 25%. The paper was fine. The translation was missing.
The Research Receivable Hiding in Your Aging Report
If your practice does any clinical trial or pharmaceutical research work, you probably have another asset class buried inside your aging report that your banker almost certainly has never noticed.
A Miami Beach imaging center we reviewed carried $413,000 in accounts receivable from pharmaceutical research sponsors — names like Lynx Medical, Gentera Medicine, Advanced Pharma CR, and ADRC Clinical Research. These are not insurance claims. They are contracted B2B receivables from pharmaceutical companies running clinical trials, sitting on conventional 30-to-60-day commercial credit terms.
On the aging report, they appeared indistinguishable from medical paper. In reality, they were a structurally superior asset — investment-grade counterparty credit, contracted payment terms, no chargemaster spread, no contractual allowances. If that same center wanted a receivable-backed facility specifically for the research book, a specialty lender would price it at 80–90% advance rates, dramatically better than the blanket borrowing base a commercial bank would apply to the whole A/R lump.
Segmenting that research book out of the medical aging changed the conversation with that center's bank completely. It also changed the conversation the owner was ready to have with their CFO about what the practice actually owned.
Stability Is the Number Your Bank Should Actually Watch
Here is the real banker number for a healthcare practice, and it is not on the aging report at all: the coefficient of variation of monthly cash collections.
Pull the last twelve months of operating-account deposits. Compute the standard deviation, divide by the monthly average, multiply by 100. That is the CV, and it tells you — and the credit team — how stable the practice's actual cash realization is, regardless of how the aging visualizes.
| CV Range | What It Means |
|---|---|
| Under 20% | Exceptional stability; credit committee dream |
| 20–30% | Healthy, normal range for a well-run practice |
| 30–40% | Acceptable but monitor for payer concentration or seasonality |
| Over 40% | Real question worth investigating |
A practice running at 21% CV on its monthly cash has a more predictable revenue line than most commercial businesses. A line of credit sized against that cash stream — at any reasonable multiple — is a much cleaner credit decision than a borrowing-base formula applied to a long-tailed receivable. If the credit team has not asked for monthly cash CV, hand it to them anyway.
What to Send Your Bank When They Ask for A/R
When a commercial banker asks for an updated A/R aging report on a radiology practice, the worst thing you can do is send them the aging report alone. The right move is to send the aging report plus a one-page translation memo that puts the numbers in the banker's language before the underwriter has a chance to reach for the wrong formula.
The template we use for this — sent from the CFO to the banker, cc'd to the practice owner and controller — has six sections and takes about twenty minutes to assemble if the underlying QuickBooks and practice management data is current:
- One-paragraph chargemaster explainer — why gross A/R is larger than expected cash, written in commercial-banking vocabulary
- Payer class breakdown — the table from above, with dollar amounts and percentages specific to the practice
- LOP counterparty table — top five to ten law firm counterparties by balance, with a one-line credit comment on each
- Monthly cash run rate and coefficient of variation — twelve months of deposits, stability ratio, and any posting-date anomalies called out directly
- Research or specialty receivables, if applicable — segmented out of the medical aging with payment terms
- "Let them do their own DSCR" — the memo deliberately does not compute the debt service coverage ratio for the banker
That last point matters. The temptation is to hand the credit committee a fully modeled DSCR calculation against the proposed line, stress-tested three ways. We used to do that. We stopped. The credit team has their own coverage formula and their own stress scenarios, and they prefer to run the math themselves — they just need the three inputs (cash run rate, stability, payer quality) delivered in a format they can plug in without Google searching what PIP means. Give them context. Let them conclude.
Most accounting firms, even well-run ones, have never had to write this memo, because most accounting firms do not sit between healthcare operators and commercial credit teams on an ongoing basis. The vocabulary is not standard-issue CPA training. But the underlying work — reading QuickBooks like an operator, reconciling cash against billing activity, knowing which payers pay what — is exactly the translation layer most practice owners are missing when the bank calls.
This is the kind of clarity that does not come from a monthly financial statement. It comes from somebody who reads healthcare A/R the way a radiologist reads an MRI — not looking at the image, but looking for what the image reveals.
One South Florida imaging center we worked with went into a line-of-credit conversation with their bank carrying an A/R that looked ugly on paper and walked out three weeks later with their requested increase approved at Prime on an interest-only structure. Nothing about the underlying practice changed. What changed was that the credit team finally saw the three numbers that mattered — gross charges, cash collected, and Net Collection Rate — in a frame they could actually evaluate. The owner slept better that weekend. Then on Monday morning, she signed the docs, closed on the equipment order she had been sitting on for six months, and moved on with her week. That started the Monday morning after she saw the numbers her own aging report had been hiding from her.
FAQ
Why is most of my radiology A/R in the 120+ day bucket? Because of how healthcare billing works, not because of a collection problem. The 120+ concentration is driven almost entirely by the Letter of Protection segment, which settles on a 12-to-36-month cycle through the personal injury litigation process. A practice with 35–45% LOP in its A/R will normally show 55–60% in 120+ days even with a perfectly run billing operation.
What is a good Net Collection Rate for a radiology practice? For a Florida radiology practice, 25–35% NCR is the normal range, depending on payer mix. The absolute number matters less than the stability: a practice holding a consistent NCR over twelve rolling months is performing correctly, even if the number looks "low" compared to commercial business expectations. Stability, not magnitude, is the billing health indicator.
Is LOP (Letter of Protection) A/R actually collectible? Yes, when it sits against tier-1 Florida personal injury firms, which is where most of it does. Morgan & Morgan, Farah & Farah, Steinger Greene, and similar established firms have multi-decade settlement histories and reliable payment practices on executed LOPs. The issue is not collectibility — it is the 12-to-36-month duration, which means charges are recognized immediately but cash realizes over the settlement cycle.
How should I explain healthcare A/R to my commercial banker? Send the aging report with a one-page translation memo covering six things: a chargemaster explainer, a payer-class breakdown, an LOP counterparty table, a twelve-month cash run rate with coefficient of variation, any specialty receivables segmented out, and raw enough data for the credit team to run their own DSCR calculation. Do not compute the DSCR for them — they prefer to run it themselves on inputs they trust.
Should I include LOP receivables in my borrowing base? Usually yes, but with a separate advance rate reflecting the longer duration. A flat commercial borrowing base that either fully includes or fully excludes LOP paper will mispricethe facility in both directions. The right conversation to have with the credit team is a tiered advance rate — higher on commercial and PIP, moderate on LOP against tier-1 firms, excluded on self-pay and unknown counterparties.
Ready to have that conversation with your bank with the numbers already on your side? Benefique's fractional CFO engagement for healthcare practices includes the A/R translation memo as standard deliverable whenever a credit event comes up. Read how accounting becomes an ROI center when the translation layer is built in.
Disclaimer: This article is for informational purposes only and does not constitute tax, legal, or financial advice. Tax and banking situations vary — consult a qualified professional for advice specific to your circumstances. Practice examples are anonymized composites based on real client data; identifying details have been changed.